Comorbid chronic inflammatory diseases influence the prognosis of alopecia areata, according to study findings.

Boulder-based Enveda Biosciences, which uses machine learning to discover naturally occurring drug compounds, plans to begin testing ENV-294, its leading drug candidate developed to treat atopic ...

Your indoor versus outdoor environment could have an even bigger impact on your eczema symptoms than you realize.

In this Q&A, Marty Becker, DVM, Elite FFCP-V and Paul Bloom, DVM, DACVD, DABVP (Canine and Feline), Elite FFCP-III share ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

Experts warn air pollution could be making your eczema worse, but there are simple ways you can help protect your skin.

An artificial intelligence (AI)-enabled hand sensor delivering closed-loop haptic feedback appeared to be an effective ...

For children with atopic dermatitis (AD), early childhood stressful life events are associated with an increased ris ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

ENV-294 is a clinical-stage small molecule designed to address the shared pathways underlying multiple inflammatory conditions via a first-in-class mechanism. ENV-294 entered Phase 1 studies in ...

A small cohort study found that a wearable hand sensor that uses artificial intelligence reduced subconscious nighttime ...

Tapinarof, however, offers a potential solution by improving the skin barrier, reducing inflammation and relieving itch ...